APOE ɛ4 carrier status has been shown to lead to a high incidence of AD [49] and DLB [50], but the effect of APOE ɛ4 on the risk of dementia and mortality diminishes or disappears with advanced age [51, 52]. Here, APOE is linked to Alzheimer disease.